Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β-converting enzyme

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 5860-5866

  Petit, Frederique ^a   Bertagnoli, Stephane ^a   Gelfi, Jacqueline ^a   Fassy, Florence ^b   Boucraut Baralon, Corine ^a   Milon, Alain ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; SERINE PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DNA LIBRARY; DNA SEQUENCE; ENZYME ACTIVITY; INFLAMMATION; NONHUMAN; OPEN READING FRAME; POXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS;

EID: 0029839388     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.5860-5866.1996     Document Type: Article

References (57)

1. Alcami, A., and G. L. Smith. 1192. A soluble receptor far interleukin-1β encoded by Vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153-167.
2. Alcami, A., and G. L. Smith. 1995. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today 16:474-478.
3. Ali, A. N., P. C. Turner, M. A. Brooks, and R. W. Mover. 1994. The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology 202:305-314.
4. Brooks, M. A., A. N. Ali, P. C. Turner, and R. W. Mover. 1995. A rabbitpox virus scrpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 69:7688-7698.
5. Carrell, R. W., P. A. Pemberton, and D. R. Boswell. 1987. The serpins: evolution and adaptation in a family of protease inhibitots. Cold Spring Harbor Symp. Quant. Biol. 52:527-535.
6. Drillien, R., D. Spehner, D. Villeval, and J.-P. Lecocq. 1987. Similar genetic organization between a region of fowlpox virus DNA and the vaccinia virus HindIII J fragment despite divergent location of the thymidine kinase gene. Virology 160:203-209.
7. Fenner, F., and K. Myers. 1978. Myxoma virus and myxomatosis in retrospect: the first quarter century of a new disease, p. 539-570. In E. Kurstok and K. Maramosch (ed.), Viruses and environment. Academic Press, New York.
8. Fenner, F., and F. N. Ratcliff. 1965. Myxomatosis in Orytolagus cuniculus: the immunological response, p. 118-133. Cambridge University Press, Cambridge.
9. Gagliardini, V., P.-A. Fernandez, R. K. K. Lee, H. C. A. Drexler, R. J. Rotello, M. C. Fishman, and J. Yuan. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-828.
10. Getting, P., P. A. Patston, and M. Schapira. 1993. The role of conformational change in serpin structure and function. Bioessays 15:461-466.
11. Graham, K. A., A. Opgenorth, C. Upton, and G. McFadden. 1992. Myxoma virus MHL ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology 191:112-124.
12. Hill, R. E., and N. D. Hastie. 1987. Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature (London) 326:96-99.
13. Hill, R. E., P. H. Shaw, P. A. Boyd, H. Baumann, and N. D. Hastie. 1984. Plasma protease inhibitors in mouse and man: divergence within the reactive center regions. Nature (London) 311:175-179.
14. Howard, A. D., M. J. Kostura, N. A. Thornberry, G. J. F. Ding, G. Limjuco, J. Weidner, J. P. Salley, K. A. Hogquist, D. D. Chaplin, R. A. Mumford, J. A. Schmidt, and M. J. Toeci. 1991. IL-1 converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31 kDa IL-1α. J. Immunol. 147:2964-2969.
15. Hu, F.-Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
16. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complementcontrol protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628-632.
17. Kettle, S., N. W. Blake, K. M. Law, and G. L. Smith. 1995. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-I) encode Mr 38.5 and 40 K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 206:136-147.
18. Komiyama, T., C. A. Ray, D. J. Pickup, A. D. Howard, N. A. Thornberry, E. B. Peterson, and G. Salvessen. 1994. Inhibition of interlcukin-1β converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J. Biol. Chem. 269:19331-19337.
19. Kordula, T., A. Dubin, H. Schooltink, A. Koj, P. C. Heinrich, and S. RoseJohn. 1993. Molecular cloning and expression of an intracellular serpin: an elastase inhibitor from horse leucocytes. Biochem. J. 293:187-193.
20. Law, K. M., and G. L. Smith. 1992. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J. Gen. Virol. 73:549-557.
21. 1s by a myxoma virus serine proteinase inhibitor. J. Biol. Chem. 268:516-521.
22. Macen, J. L., C. Upton, N. Nation, and G. McFadden. 1993. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology 195:348-363.
23. Massung, R. F., V. Jayarama, and R. W. Mover. 1993. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 197:511-528.
24. McFadden, G., K. Graham, K. Ellison, M. Barry, J. Macen, M. Schreiber, K. Mossman, P. Nash, A. Lalani, and H. Everett. 1995. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J. Leukocyte Biol. 57: 731-738.
25. McKenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245-1250.
26. Odake, S., C. M. Kam, L. Narasimhan, M. Poe, J. T. Blake, O. Krahenbuhl, J. Tshopp, and J. C. Powers. 1991. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarin. Biochemistry 30:2217-2227.
27. Opgenorth, A., K. Graham, N. Nation, D. Strayer, and G. McFadden. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, MHL and myxoma growth factor. J. Virol. 66:4720-4731.
28. Opgenorth, A., D. Strayer, C. Upton, and G. McFadden. 1992. Deletion of the growth factor gene related to EGF and TGFα reduces virulence of malignant rabbit fibroma virus. Virology 186:175-191.
29. O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1994. Baculovirus expression vectors: a laboratory manual Oxford University Press, New York.
30. Palumbo, G. J., R. M. Buller, and W. C. Glasgow. 1994. Multigenic evasion of inflammation by poxviruses. J. Virol. 68:1737-1749.
31. Pickup, D. J., B. S. Ink, C. A. Ray, and W. K. Joklik. 1986. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. USA 83:7698-7702.
32. Quan, L. T., A. Caputo, R. C. Bleakley, D. J. Pickup, and G. Salvesen. 1995. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:10377-10379.
33. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69:597-604.
34. Russel, R. J., and S. J. Robbins. 1989. Cloning and molecular characterization of the myxoma virus genome. Virology 170:147-159.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
36. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
37. Saurat, P., Y. Gilbert, and J.-P. Ganière. 1978. Etude d'une souche de virus myxomateux modifié. Rev. Med. Vet. 129:415-451.
38. Shi, L., C. M. Kam, J. C. Powers, R. Aebersold, and A. H. Greenberg. 1992. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoplosis through distinct substrate and target cell interactions. J. Exp. Med. 176:1521-1529.
39. Sleath, P. R., R. C. Hendrickson, S. R. Kronheim, C. J. March, and R. A. Black. 1990. Substrate specificity of the protease that processes human interleukin-1β. J. Biol. Chem. 265:14526-14528.
40. Smith, C. A., T. Davis, J. M. Wignall, W. S. Din, T. Farrah, C. Upton, G. McFadden, and R. G. Goodwin. 1991. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176:335-342.
41. Smith, G. L. 1993. Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74:1725-1740.
42. Smith, G. L., S. T. Howard, and Y. S. Chan. 1989. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J. Gen. Virol. 70:2333-2343.
43. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. L. Buller, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152.
44. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
45. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, and V. M. Dixit, 1995. Yama CPP32 beta, a mammalian homolog of ced-3, is a CrmA inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81:801-809.
46. Tewari, M., W. G. Telford, R. A. Miller, and V. M. Dixit. 1995. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 270:22705-22708.
47. Thompson, J. P., P. C. Turner, A. N. Ali, B. C. Crenshaw, and R. W. Moyer. 1993. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. Virology 197:328-338.
48. Turner, P. C., and R. W. Moyer. 1992. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J. Virol. 66:2076-2085.
49. Turner, P. C., P. Y. Musy, and R. W. Moyer. 1995. Poxvirus serpins, p. 67-88. In G. McFadden (ed.), Viroceptors, virokines and related immune modulators encoded by DNA viruses. R. G. Landes Company, Austin, Tex.
50. Upton, C., J. L. Macen, and G. McFadden. 1987. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J. Virol. 61:1271-1275.
51. Upton, C., J. L. Macen, M. Schreiber, and G. McFadden. 1991. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370-382.
52. Upton, C., J. L. Macen, D. S. Wishart, and G. McFadden. 1990. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology 179:618-631.
53. Upton, C., and G. McFadden. 1986. Identification and nuclcotide sequence of the thymidine kinase gene of Shope fibroma virus. J. Virol. 60:920-927.
54. Upton, C., and G. McFadden. 1986. Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology 152:308-321.
55. Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the gamma-IFN receptor by myxoma virus. Science 258:1369-1372.
56. Upton, C., A. Opgenorth, P. Traktman, and G. McFadden. 1990. Identification and DNA sequence of the Shope fibroma virus DNA topoisomerase gene. Virology 176:439-447.
57. Zhou, J., X. Y. Sun, G. J. P. Fernando, and I. H. Frazer. 1992. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology 189:678-686.